Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Shionogi Stories

2014-04-02 08:32:38

BRANFORD, Conn., April 2, 2014 /PRNewswire/ -- New Haven Pharmaceuticals, Inc. (the "Company"), a privately held specialty pharmaceuticals company, today announced the appointment of Larry Dillaha, M.D., to the newly-created position of Executive Vice President Operations. Dr. Dillaha joins the Company from Insys Therapeutics, Inc. (Nasdaq: INSY) where he served as Chief Medical Officer since April 2010. "We are delighted to welcome Larry, who will provide significant insight and...

2012-04-19 10:26:26

PARSIPPANY, N.J., April 19, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has launched an authorized generic version of FORTAMET® (metformin hydrochloride extended-release tablets) as part of an agreement with Shionogi, Inc. Watson began shipping the product today. FORTAMET® is indicated as an adjunct to diet and exercise to lower blood glucose for patients 17 years of age or older. For the most recent twelve months ending February...

2012-04-02 10:25:12

CINCINNATI, April 2, 2012 /PRNewswire/ -- Prasco Laboratories announced it is expanding its supply agreement with Shionogi Inc. Under the terms of the agreement, Prasco will market and distribute the Authorized Generic version of SULAR® (Nisoldipine) Extended Release Tablets in 8.5 mg, 17 mg, and 34 mg strengths in the U.S. under the Prasco label. The financial terms of the agreement were not disclosed. Nisoldipine Extended Release Tablets are AB-rated, therapeutically equivalent and...

2012-02-21 09:00:00

ATLANTA, Feb. 21, 2012 /PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, GA, announced today that Leslie Zacks has joined the company as General Counsel and Chief Compliance Officer. Mr. Zacks has a distinguished legal career and most recently held positions of increasing responsibility at Shionogi Pharma, Inc. (previously Sciele Pharma). While at Shionogi, Leslie built the company's legal department and served on the company's executive leadership...

2011-11-18 02:00:00

NYON, Switzerland and PHILADELPHIA, November 18, 2011 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has entered into an agreement with Shionogi & Co. Ltd. of Japan to co-develop and co-commercialize certain of Shire's Attention Deficit Hyperactivity Disorder (ADHD) medicines in Japan. Shionogi will pay a one time fee and share costs with Shire in exchange for rights to jointly co-develop and...

2011-08-22 10:00:00

CINCINNATI, Aug. 22, 2011 /PRNewswire/ -- Prasco Laboratories, the Authorized Generics company, announced today it has signed a supply agreement with Shionogi Inc. Under the terms of the agreement, Prasco will market and distribute Nitrofurantoin Oral Suspension, the Authorized Generic version of Furadantin® Oral Suspension. Prasco intends to begin shipping product immediately in the U.S. under the Prasco label. "Prasco is pleased to work with Shionogi to extend another...

2011-08-04 07:00:00

FLORHAM PARK, N.J., Aug. 4, 2011 /PRNewswire/ -- It's back-to-school season and for many families, that means new morning routines, homework and head lice. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/shionogi/50422/ (Photo: http://photos.prnewswire.com/prnh/20110804/MM45457 ) Each year, approximately 6 to 12 million children in the U.S. are infested with this common, six-legged critter that feeds on human blood. After weeks...

2011-07-25 08:00:00

CINCINNATI, July 25, 2011 /PRNewswire/ -- Prasco Laboratories, the Authorized Generics company, announced today it has signed a supply agreement with Shionogi Inc. Under the terms of the agreement, Prasco will market and distribute Mefenamic Acid Capsules, USP 250 mg, the Authorized Generic version of Ponstel(®). Prasco intends to begin shipping product immediately in the U.S. under the Prasco label. "With the introduction of the authorized generic of Shionogi's...

2010-12-17 06:30:00

PITTSBURGH, Dec. 17, 2010 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Shionogi Pharma Inc. and CIMA LABS INC. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Prednisolone Sodium Phosphate Orally Disintegrating Tablets, 10 mg, 15 mg and 30 mg. This product is the generic version of Orapred ODT®, a...

2010-09-06 13:55:00

ANTONY, France, September 6, 2010 /PRNewswire-FirstCall/ -- Stallergenes S.A. has announced today the signing of exclusive partnership agreements with Shionogi & Co., Ltd. for two sublingual allergen immunotherapy tablet products resulting from the Stalair(R) program: Actair(R) house dust mite tablets and Japanese cedar pollen tablets. With 32 million respiratory allergy sufferers, there is a strong - and as yet unmet - demand for treatment in Japan, where sublingual allergen...